Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer

OBJECTIVES: This analysis investigated nomogram use to evaluate metastatic pancreatic cancer prognosis. METHODS: Thirty-four baseline factors were examined in the Metastatic Pancreatic Adenocarcinoma Clinical Trial (MPACT) (nab-paclitaxel plus gemcitabine vs gemcitabine) data set. Factors significan...

全面介紹

Na minha lista:
書目詳細資料
發表在:Pancreas
Main Authors: Goldstein, David, Von Hoff, Daniel D., Chiorean, E. Gabriela, Reni, Michele, Tabernero, Josep, Ramanathan, Ramesh K., Botteman, Marc, Aly, Abdalla, Margunato-Debay, Sandra, Lu, Brian, Louis, Chrystal U., McGovern, Desmond, Lee, Chee Khoon
格式: Artigo
語言:Inglês
出版: Lippincott Williams & Wilkins 2020
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314499/
https://ncbi.nlm.nih.gov/pubmed/32541630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPA.0000000000001563
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍